Arunya Jiraviriyakul

5PUBLICATIONS
4CO-AUTHORS
Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)Major global burdens of diseaseMolecular targetsAnimal protection (incl. pests and pathogens)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 07, 2025
High Mobility Group Box 1 Is Potential Target Therapy for Inhibiting Metastasis and Enhancing Drug Sensitivity of Hepatocellular Carcinoma.

Arunya Jiraviriyakul, Chatchai Nensat, Samitanan Promchai

|Jan 08, 2025
Potential Serum HMGB1, HSP90, and S100A9 as Metastasis Predictive Biomarkers for Cancer Patients and Relevant Cytokines: A Pilot Study.

Worawat Songjang, Chatchai Nensat, Wittawat Jitpewngarm

|Sep 23, 2022
Tumor-Promoting Activity and Proteomic Profiling of Cisplatin/Oxaliplatin-Derived DAMPs in Cholangiocarcinoma Cells.

Worawat Songjang, Chatchai Nensat, Nitirut Nernpermpisooth

|Feb 19, 2021
Porcine placenta extract improves high-glucose-induced angiogenesis impairment.

Chatchai Nensat, Worawat Songjang, Rutaiwan Tohtong

Pageof 1